DXR — DAXOR CORP
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 27367 ·
Last close
$10.56
Market Cap
$61.51M
52W High
$12.31
52W Low
$8.56
ADV30
7,641
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 46,009,861 | — | 122,595 |
| Jun 2025 | — | — | — | — | 35,900,241 | — | 272,427 |
| Dec 2024 | — | — | — | — | 36,632,597 | — | 840,296 |
Balance + Analyst (yfinance extras)
Retained Earnings
$34,799,231
Inventory
—
Receivables
$1,813
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$26,688
EBITDA
—
Free Cash Flow
$100,248
Enterprise Value
—
Total Cash
—
Total Debt
$0
Shares Out
5,827,225
Trailing EPS
$1.64
Book Value
$9.07
ROE
22.5%
ROA
-1.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,303,455 | — | 9,169,774 | 46,009,861 | 122,595 | — | 570,936 |
| Dec 2024 | 2,130,893 | — | 536,334 | 36,632,597 | 840,296 | — | 25,692 |
| Dec 2023 | 1,280,515 | — | 280,640 | 34,869,142 | 858,758 | — | -3,655,068 |
| Dec 2022 | 6,310,294 | — | 5,178,133 | 30,261,069 | 1,291,600 | — | -769,298 |
News headlines (Yahoo Finance, 1h cache)
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
2026-04-28 12:00 · Yahoo
Dynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF Series
2026-04-20 13:00 · Yahoo
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
2026-04-08 12:00 · Yahoo
Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
2026-03-26 12:00 · Yahoo
Dynamic announces March 2026 cash distributions for Dynamic Active ETFs and ETF Series
2026-03-19 13:00 · Yahoo
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
2026-03-17 12:00 · Yahoo
Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha
2026-03-15 15:15 · Yahoo
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
2026-03-10 13:00 · Yahoo
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
2026-03-10 12:00 · Yahoo
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026
2026-03-09 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.